Indicators of chymase-positive MCs in the lungs of patients with COVID-19 are presented in statistically significantly lower numbers than in controls, while the content of CPA3-positive MCs and their degranulation activity are higher in patients with COVID-19. The gene discussed is CPA3; the disease is COVID-19.